Zhang Hui, Xu Cheng-Feng, Ren Chao, Wu Tian-Tian, Dong Ning, Yao Yong-Ming
Cell Physiol Biochem. 2018;51(1):452-469. doi: 10.1159/000495241. Epub 2018 Nov 19.
BACKGROUND/AIMS: Immunosuppression frequently occurs during the development of sepsis and is closely associated with poor outcome. Characteristics of immunosuppressive CD4+ T lymphocytes in sepsis have been reported to include dramatic cell loss and inactivation. p53 acts as a pivotal transcription factor in regulating cell proliferation and apoptosis, which control tumorigenesis. However, few studies have investigated the universal role of p53 in immune cells, especially in the development of sepsis.
A mouse model of sepsis was produced by cecal ligation and puncture (CLP), and isolated splenic CD4+ T cells or Jurkat cells were exposed to lipopolysaccharide (LPS) stimulation in vitro. We used genetic knockout (p53-/-) mice or the specific inhibitor pifithrin-α (PFT) to investigate the regulatory mechanisms of p53. Cell proliferation ability was assessed using a Cell Counting Kit-8 assay, and apoptotic cells were stained with annexin V/propidium iodide and then analyzed using a FACScan flow cytometer. Protein and mRNA expression levels were measured by western blotting and real-time PCR, and cytokine levels in culture supernatants were determined by enzyme-linked immunosorbent assay.
Splenic CD4+ T lymphocytes from CLP mice expressed gradually elevated p53 mRNA and protein levels, which resulted in extracellular regulated protein kinase 1/2 inactivation and expression of apoptotic molecules. Specific inhibition of p53 by PFT or genetic knockout (p53-/-) maintained CD4+ T lymphocyte homeostasis, as indicated by protection from cell loss and restoration of immune function. A medium dose of PFT improved the survival rate of mice, while mortality rate showed only a slight improvement in p53-/- mice compared with wild-type mice. The in vitro responses to LPS were consistent with these results, and upregulation of p53 clearly affected the proliferation, apoptosis, and immune dysfunction of CD4+ T lymphocytes. In addition, we confirmed the regulatory effect of p53 in Jurkat cells, and inhibition of p53 by either inhibition or short hairpin RNA transduction markedly protected cells from LPS stimulation.
Elevation of p53 in T lymphocytes during sepsis or endotoxin challenge might be responsible for inhibiting cell proliferation and enhancing both apoptosis and immune dysfunction of T cells.
背景/目的:脓毒症发展过程中常出现免疫抑制,且与不良预后密切相关。据报道,脓毒症中免疫抑制性CD4+ T淋巴细胞的特征包括大量细胞丢失和失活。p53作为一种关键转录因子,在调节细胞增殖和凋亡中发挥作用,而细胞增殖和凋亡控制着肿瘤发生。然而,很少有研究探讨p53在免疫细胞中的普遍作用,尤其是在脓毒症发展过程中的作用。
通过盲肠结扎和穿刺(CLP)建立脓毒症小鼠模型,并将分离的脾CD4+ T细胞或Jurkat细胞在体外暴露于脂多糖(LPS)刺激。我们使用基因敲除(p53-/-)小鼠或特异性抑制剂pifithrin-α(PFT)来研究p53的调节机制。使用细胞计数试剂盒-8检测评估细胞增殖能力,用膜联蛋白V/碘化丙啶对凋亡细胞进行染色,然后使用FACScan流式细胞仪进行分析。通过蛋白质印迹和实时PCR测量蛋白质和mRNA表达水平,并用酶联免疫吸附测定法测定培养上清液中的细胞因子水平。
CLP小鼠的脾CD4+ T淋巴细胞中p53 mRNA和蛋白质水平逐渐升高,导致细胞外调节蛋白激酶1/2失活和凋亡分子表达。PFT对p53的特异性抑制或基因敲除(p53-/-)维持了CD4+ T淋巴细胞的稳态,表现为防止细胞丢失和免疫功能恢复。中等剂量的PFT提高了小鼠的存活率,而与野生型小鼠相比,p53-/-小鼠的死亡率仅略有改善。对LPS的体外反应与这些结果一致,p53的上调明显影响CD4+ T淋巴细胞的增殖、凋亡和免疫功能障碍。此外,我们证实了p53在Jurkat细胞中的调节作用,通过抑制或短发夹RNA转导抑制p53可显著保护细胞免受LPS刺激。
脓毒症或内毒素攻击期间T淋巴细胞中p53升高可能是抑制细胞增殖、增强T细胞凋亡和免疫功能障碍的原因。